HTGC

NYSE: HTGC (Stock Quote) $13.33 $0.14 1.06%
NYSE: HTGZ (Bond Quote) $26.21 $0.30 +1.16%
NYSE: HTGY (Bond Quote) $26.15 $0.11 +0.42%
  • Company
    • Investment Focus
    • Financing Solutions
      • Technology
      • Cleantech
      • Life Science
      • Special-Opportunity Lower Middle Market
    • Venture Capital & Private Equity
    • Giving Back to the Community
    • Careers
  • Team
    • Investment Professionals
      • Technology
      • Cleantech
      • Life Science
      • Special-Opportunity Lower Middle Market
    • Management
    • Board of Directors
    • Team A-Z
  • Portfolio
    • Technology
    • Cleantech
    • Life Science
    • Special-Opportunity Lower Middle Market
    • Exit History
    • A-Z Portfolio List
  • Investor Relations
    • News & Events
      • Press Releases
      • Webcasts & Events
    • Financials & Filings
      • Analyst Coverage
      • Annual Reports
      • Dividends
        • Dividend Reinvestment Plan
      • Financial Statements
      • Quarterly Results
      • SEC Filings
      • Stock Information
        • Stock Performance
        • Historic Stock Lookup
        • Calculator
      • Tax Information
      • Email Alert Subscription
    • Corporate Governance
      • Corporate Governance Guidelines
      • Audit Committee
      • Compensation Comittee
      • Insider Ownership
      • Insider Transactions
    • Company Information
      • Company Information
      • Executive Management
      • Investor FAQs
      • IR Contact
      • Major Shareholders
    • Credit Ratings
    • What is a BDC
    • Shareholder Tools
      • Investor Briefcase
      • Download Library
      • Printed Materials
      • RSS News Feeds
  • News & Events
    • Press Releases
    • Hercules in the News
    • Portfolio Company News
    • Webcast & Events
  • Venture Debt
  • Contact

Life Science Team

The Life Science team has deep domain expertise in biotechnology, pharmaceutical development and medical device technology. The team has a successful track record in helping portfolio companies to strategically navigate the regulatory environment and bringing new therapies to market through customized financing solutions.
  • Technology
  • Cleantech
  • Life Science
  • Special-Opportunity Lower Middle Market
Home » Team » Life Science
Austin
Sherwindt
Parag I.
Shah
Janice
Bourque
Bryan R.
Jadot
Chad
Norman
Michael
Bowden
Himani
Bhalla

© 2013 Hercules Technology Growth Capital. All rights reserved. Problems with the site? Email webmaster@htgc.com
Terms of Use & Privacy Policy
*Historical, intraday and current end-of-day data provided by eSignal. Intraday data is at least 20-minutes delayed.